Gilead Sciences (GILD) Q4 Revenue Tops Views, Offers Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $150.11 -0.52%
EPS Growth %: -14.2%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -14.2%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.78, $0.11 better than the analyst estimate of $1.67. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.74 billion.
GUIDANCE:
Gilead Sciences sees FY2018 revenue of $20-21 billion, versus the consensus of $21.97 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
